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Aspergillus fumigatus, a ubiquitous airborne fungus, can cause invasive infection in immunocompromised
individuals but also triggers allergic bronchopulmonary aspergillosis in a subset of otherwise healthy indi-
viduals repeatedly exposed to the organism. This study addresses a critical gap in our understanding of the
immunoregulation in response to repeated exposure to A. fumigatus conidia. C57BL/6 mice were challenged
intranasally with A. fumigatus conidia weekly, and leukocyte composition, activation, and cytokine production
were examined after two, four, and eight challenges. Approximately 99% of A. fumigatus conidia were cleared
within 24 h after inoculation, and repeated exposure to A. fumigatus conidia did not result in hyphal growth or
accumulation of conidia with time. After 2 challenges, there was an early influx of neutrophils and regulatory
T (Treg) cells into the lungs but minimal inflammation. Repeated exposure promoted sustained expansion of
the draining lymph nodes, while the influx of eosinophils and other myeloid cells into the lungs peaked after
four exposures and then decreased despite continued A. fumigatus challenges. Goblet cell metaplasia and
low-level fibrosis were evident during the response. Repeated exposure to A. fumigatus conidia induced T cell
activation in the lungs and the codevelopment by four exposures of TH1, TH2, and TH17 responses in the lungs,
which were maintained through eight exposures. Changes in CD4 T cell polarization or Treg numbers did not
account for the reduction in myeloid cell numbers later in the response, suggesting a non-T-cell regulatory
pathway involved in dampening inflammation during repeated exposure to A. fumigatus conidia.
Allergic bronchopulmonary aspergillosis (ABPA) is char-
acterized by early allergic and late-phase lung injury in re-
sponse to repeated exposures to Aspergillus antigens, which
are the consequence of persistent fungal colonization of the
lungs (47, 60). The disease occurs primarily in patients who
have skewed pulmonary immune responses, such as those
found in atopic asthma or cystic fibrosis. The pulmonary
immune response in these patients includes a strong T
helper 2 (TH2) response to the colonizing fungus. The un-
derlying mechanism(s) by which Aspergillus induces TH2 re-
sponses in some patients, but not others, is presently un-
known. If undiagnosed, ABPA can result in progressive lung
damage, pulmonary fibrosis, and death (47, 60).
Aspergillus fumigatus conidia are frequently inhaled into air-
ways at a rate of several thousand a day (41), and pulmonary
exposure to large numbers of conidia is not uncommon (24).
Upon reaching the warm, moist environment of the lungs, the
conidia lose their hydrophobic properties and begin to germi-
nate (34). Following conidial swelling and germ tube extension,
the fungus develops invasive hyphae (54), and the cycle repeats
itself. Although A. fumigatus can pose a serious threat to im-
munocompromised individuals, even relatively large doses of
conidia pose little danger to immunocompetent hosts.
The immune response to inhaled A. fumigatus in healthy
individuals is characterized by a complex interaction between
innate and adaptive immune responses, both of which are
activated upon exposure to the fungus (18, 31, 56, 58). Mac-
rophages and neutrophils efficiently phagocytize inhaled
conidia in the lungs, with neutrophils being absolutely essen-
tial, and conidial clearance can occur with minimal inflamma-
tion (7, 33, 44, 63, 66, 67, 70). Invasive infection of humans is
associated with decreased gamma interferon (IFN-) produc-
tion and poor T cell proliferation (27), and inhibition of IFN-
or tumor necrosis factor alpha (TNF-) enhances fungal inva-
sion (2, 14, 43). A single inhalation of aerosolized A. fumigatus
spores by mice can induce the expression of TNF-, IFN-,
interleukin 12 (IL-12), and IL-18 (10). In an adoptive transfer
model, A. fumigatus-specific CD4 T cells are rapidly primed
in lung-associated lymph nodes by CCR2 Ly6Chi monocytes/
dendritic cells, and these CD4 T cells differentiate fully into
IFN--producing TH1 cells upon arrival in the airways (30, 62).
Most studies have focused on the host response following
one exposure or a very limited number of exposures to A.
fumigatus conidia. While repeated exposure to A. fumigatus
conidia is common, little is known about the evolution and
regulation of the host response to repeated exposure to A.
fumigatus conidia. There is a significant body of literature on
the pulmonary allergic response to a conidial challenge of mice
previously sensitized by intraperitoneal injection of Aspergillus
antigen extracts in an adjuvant (6, 40), which has provided
much information about the mechanisms underlying TH2-me-
diated pathological changes in the lungs. In addition, we have
previously reported that two intranasal exposures to A. fumiga-
tus conidia without a sensitizing event do not result in pulmo-
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nary allergic inflammation (51, 52). Our current study ad-
dresses a critical gap in our understanding of the regulation
and evolution of adaptive immune responses to repeated ex-
posures to A. fumigatus conidia. We set out to test the hypoth-
esis that while two airway exposures to A. fumigatus conidia
stimulate an innate response (neutrophils and macrophages)
and begin priming for a Th1 response to the fungus, repeated
exposures also stimulate the development of both TH2 and
TH17 cells, which coincides with the development of a robust
inflammatory response in the lungs.
MATERIALS AND METHODS
Mice. Wild-type (C57BL/6J) mice obtained from the Jackson Laboratories
(Bar Harbor, ME) were housed under pathogen-free conditions in enclosed
filter-top cages. Clean food and water were given ad libitum. The mice were
handled and maintained using microisolator techniques, with daily veterinarian
monitoring. All studies involving mice were approved by the University Com-
mittee on Use and Care of Animals at the University of Michigan.
Aspergillus fumigatus. Strain ATCC 13073 was grown on Sabouraud dextrose
agar (SDA; Difco) for 14 days. Conidia were harvested by washing plates with
sterile phosphate-buffered saline (PBS; pH 7.4) with 0.1% Tween 80 (PBS-
Tween), followed by filtration of the suspension through two layers of sterile
gauze to remove hyphae. Conidia were washed in PBS-Tween, counted with a
hemocytometer, diluted to 108 spores/ml in sterile PBS-Tween, and stored at 4°C
for as long as 4 months. The conidial preps consisted of 99.9% resting conidia
and did not contain appreciable numbers of swollen conidia. The viability of the
conidial stocks, as assessed by dilution plating, remained reproducible and high.
Intranasal challenge. To achieve sedation, mice were injected intraperitone-
ally with 0.4 mg/ml xylazine (Lloyd Laboratories, Shenandoah, IA) and 10 mg/ml
ketamine (Fort Dodge Animal Health, Fort Dodge, IA) in sterile saline (Hos-
pira, Inc., Lake Forest, IL) based on weight. Following sedation, 20 l of an
Aspergillus fumigatus suspension was administered intranasally for a total of 2 
106 conidia per mouse per challenge.
Lung histology. Lungs were fixed by inflation with 10% neutral buffered
formalin (Sigma). After paraffin embedding, 5-m-thick sections were cut and
stained with either hematoxylin and eosin (H&E) for histological analysis, peri-
odic acid-Schiff stain (PAS) for the detection of mucus and goblet cell metapla-
sia, Masson’s trichrome stain for the detection of collagen deposition, or Gro-
cott’s methenamine silver (GMS) stain for the detection of conidia and hyphae
(McClinchey Histology Lab, Stockbridge, MI).
Lung digestion for whole-lung leukocyte enrichment. Lungs from each mouse
were excised, washed in PBS, minced, and digested enzymatically for 30 min in
15 ml/lung of digestion buffer (RPMI medium, 5% fetal calf serum, 1 mg/ml
collagenase [Boehringer Mannheim Biochemical, Chicago, IL], and 30 g/ml
DNase [Sigma Chemical Co., St. Louis, MO]) as previously described (50). After
erythrocyte lysis using NH4Cl buffer (0.83% NH4Cl, 0.1% KHCO3, 0.037%
disodium EDTA [pH 7.4]), cells were washed, resuspended in RPMI medium
with 5% fetal calf serum and 20% Percoll (Sigma), and centrifuged for 30 min at
2,000  g to separate leukocytes from cell debris and epithelial cells. Total-lung
leukocyte numbers were enumerated in the presence of trypan blue by using a
hemocytometer.
In vivo quantification of viable conidia. Following digestion of the lung, an
aliquot was taken for analysis prior to centrifugation and erythrocyte lysis. The
sample was serially diluted and plated onto SDA in duplicate. Individual mycelial
colonies were counted to determine the number of CFU per dilution, which was
then multiplied to yield the total number of viable conidia in the lungs of each
mouse 24 h after inoculation.
Isolation of lymph node cells. The draining mediastinal lymph node was
excised from the thoracic cavity, placed in 1 ml of RPMI medium (with 5% fetal
calf serum) in a six-well plate (Corning Incorporated, Corning, NY), and ground
with the flat edge of a 1-ml syringe. The cell suspension was then transferred
through a 100-m-pore-size screen and was washed with 2 ml of RPMI medium.
After erythrocyte lysis using NH4Cl buffer, cells were washed, resuspended in
RPMI medium (with 5% fetal calf serum), and counted with a hemocytometer
prior to analysis.
Flow cytometry. Cells were washed and resuspended at a concentration of
106/25 l FA buffer (Difco) plus 0.1% NaN3, and Fc receptors were blocked by
the addition of unlabeled anti-CD16/32 (Fc Block; BD Pharmingen, San Diego,
CA). After Fc receptor blocking, 0.5 106 to 1 106 cells were stained in a final
volume of 50 l in 96-well round-bottom plates (Corning Incorporated, Corning,
NY) for 30 min at 4°C. Cells were washed twice with FA buffer, resuspended in
120 l of 4% formalin (Sigma), and transferred to 12- by 75-mm polystyrene
tubes (Becton Dickinson, Franklin Lakes, NJ). A minimum of 100,000 events
were acquired on a FACSCanto flow cytometer (BD Pharmingen) using
CellQuest software (BD Pharmingen). The data acquired were analyzed with
FlowJo software (Tree Star, Stanford, CA). Fluorochrome-conjugated antibod-
ies directed against the following antigens were obtained: CD45 (BioLegend, San
Diego, CA); CD3, CD4, CD8, CD11c, CD19, CD25, CD44, CD49b, CD69, Gr1,
Siglec F, FcεRI, IFN-, IL-4, IL-10, and IL-17 (BD Pharmingen); and Foxp3
(eBioscience, San Diego, CA).
Differential analysis. Cells from whole-lung digests were analyzed as follows.
First, lung leukocytes were identified by CD45 expression. The following leuko-
cyte subsets were then identified within this gate: (i) neutrophils, identified using
a CD11c-versus-Gr1 plot as cells expressing little CD11c but large amounts of
Gr1; (ii) mature eosinophils, identified as cells expressing moderate amounts of
CD11c and Gr1 and further expressing large amounts of Siglec F; and (iii)
lymphocytes, identified within the population of cells displaying low forward and
side scatter and then subdivided into CD4, CD8, or B cells (CD19), based on cell
surface staining. Basophils were identified as FSClow SSClow cells that were Gr1
CD11c CD3 CD19 CD49b FcεRI as described previously (53). Mono-
cytes/macrophages/dendritic cells (DC) represent a continuum of myeloid dif-
ferentiation, and the cell surface markers required to fully differentiate specific
myeloid populations were not used in this study. These cells were analyzed in
aggregate and were identified based on their forward and side scatter charac-
teristics, lack of lymphocyte markers, and exclusion of the neutrophil and eosin-
ophil populations (described above). Where possible, changes in the cell differ-
entials were also confirmed by Wright-Giemsa stains of cytospin slides.
CD4 T cell activation. CD4 T cells in the lungs and lymph nodes were iden-
tified by CD45 and CD4 staining. Cells were additionally stained with fluores-
cently labeled antibodies specific for CD44 and CD69, both of which are markers
of T cell activation. CD4 T cells that were CD44high CD69 were counted as
activated.
Intracellular flow staining. Prior to intracellular cytokine staining, cells were
stimulated in vitro for 6 h with phorbol myristate acetate (PMA) (50 ng/ml) and
ionomycin (1 g/ml) in the presence of brefeldin A (BD Pharmingen) to pro-
mote the intracellular accumulation of cytokines. After stimulation, cells were
washed twice prior to surface molecule staining. Subsequently, intracellular mol-
ecules were stained using the BD Cytofix/Cytoperm kit according to the manu-
facturer’s instructions (BD Pharmingen).
Blood collection and serum separation. Blood was collected from mice at the
time of harvest. Serum was collected after centrifugation for 1 min at 6,000 rpm
in Microtainer tubes (BD Pharmingen).
Enzyme-linked immunosorbent assay. IgE in serum was measured by a sand-
wich enzyme-linked immunosorbent assay (sandwich ELISA) using the manu-
facturer’s instructions supplied with the specific kits (BD Pharmingen).
Bronchoalveolar lavage (BAL) for cell recovery (intermittent challenge exper-
iment). Airway contents were recovered by the instillation and retrieval of 1 ml
of sterile PBS through a tracheotomy tube. Cells collected by three total lavages
were pooled. After erythrocyte lysis using NH4Cl buffer, cells were washed,
resuspended in complete medium (RPMI 1640, 10% fetal calf serum, 2 mmol/
liter L-glutamine, 50 mol/liter 2-mercaptoethanol, 100 U/ml penicillin, 100
g/ml streptomycin sulfate), and enumerated under a light microscope in the
presence of trypan blue by using a hemocytometer.
Statistical analyses. At least four separate experiments (Fig. 2 to 8) or two
separate experiments (Fig. 9) with 3 to 4 mice per group per experiment were
performed. The quantitative data in each graph are from the cumulative analysis
across the multiple experiments (i.e., the graphs do not show results for a single
representative data set). All values are reported as means  standard errors of
the means. Differences between groups were evaluated by analysis of variance
(ANOVA) with a posthoc test; a P value of 	0.05 was considered statistically
significant.
RESULTS
Cellular infiltrate and airway remodeling following repeated
pulmonary exposure to Aspergillus conidia. To determine the
host response to repeated exposure to A. fumigatus conidia,
mice were challenged intranasally once a week for 2, 4, or 8
weeks with 2 106 live A. fumigatus conidia and were analyzed
24 h after the final conidial challenge. This intranasal exposure
dose is 5- to 100-fold lower than that typically used by labs in
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studies of invasive aspergillosis (43, 46, 63, 76). We prepared
histological sections of the lungs and analyzed pulmonary in-
flammation (H&E), goblet cell metaplasia (PAS), and fibrosis
(trichrome). Following two challenges, granulocytic infiltrates
were beginning to become evident around the airways, with
minimal changes in goblet cells or collagen deposition (Fig.
1A). After four challenges, the size of the inflammatory infil-
trate had increased markedly around the airways and in the
parenchyma, including large numbers of eosinophils and neu-
trophils and the formation of multinucleated giant cells (Fig.
1B). In addition, goblet cell metaplasia in the epithelium was
now evident, along with low-level fibrotic changes (Fig. 1A).
Following eight challenges, inflammatory infiltrates, goblet cell
metaplasia, and fibrotic changes were still histologically evi-
dent, but all were either at the same level or a lower level than
those observed at four challenges, though still greater than
those observed at two challenges (Fig. 1A). Despite repeated
challenges and diminished pulmonary inflammation, the sur-
vival rate over the course of 8 weeks was 100% (data not
shown). Thus, repeated exposure of C57BL/6 mice to A. fu-
migatus conidia induced a marked pulmonary inflammatory
response between 2 and 4 weeks of conidial challenge; how-
ever, the magnitude of the pulmonary inflammatory response
did not continue to amplify despite continued A. fumigatus
challenges.
Fungal clearance and expansion of cellular populations in
the lungs and lymph nodes following two, four, and eight
conidial challenges. We next addressed the question of
whether the changes in the pulmonary inflammatory response
with increasing exposures were accompanied by changes in
conidial clearance. The numbers of viable conidia in the lungs
were quantified at each time point, as described in Materials
and Methods. Twenty-four hours after inoculation, the initial
number of conidia (2  106) administered to the lungs had
been reduced to less than 2  104 viable conidia; levels of
conidial clearance at 24 h postinoculation were identical for
the mice in the two-, four-, and eight-challenge groups, regard-
less of differences in the inflammatory response between these
FIG. 1. (A) Cellular infiltrate around the airways, goblet cell metaplasia, and collagen deposition following repeated intranasal exposure to
Aspergillus fumigatus conidia. Lungs from nonchallenged mice (Untreated) and from mice challenged two, four, or eight times were fixed in
formalin and embedded in paraffin blocks. Histological slices were then stained with either H&E, PAS, or Masson’s trichrome stain. Magnifica-
tions, 400 for H&E and PAS; 200 for trichrome. (B) Multinucleated giant cells were observed in the lungs of mice challenged four times with
conidia. Magnifications are given below the images.
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time points (Fig. 1 and 2A). By silver staining, we could occa-
sionally identify very small numbers of conidia but never ob-
served hyphal masses. Most commonly, we could not identify
any significant amount of fungal material at sites of inflamma-
tion or other uninvolved regions of the lungs by silver staining
(data not shown). We did occasionally observe rare germinat-
ing conidia in some mice (data not shown), which is worth
noting because germinating conidia are metabolically active
and reorganize the contents of their cell walls to expose im-
munostimulatory glucans (32, 70). Thus, approximately 99% of
A. fumigatus conidia were cleared within 24 h of inoculation,
and repeated exposure to A. fumigatus conidia did not result in
hyphal growth or accumulation of conidia with time.
To provide a quantitative analysis of the kinetics of the
pulmonary inflammatory response, leukocytes were isolated
from enzymatically dispersed lungs of challenged mice 24 h
after final challenge at each time point. Two challenges stim-
ulated the influx of a small number of leukocytes into the lungs
and expansion of the draining mediastinal lymph nodes (Fig.
2B). Repeated challenges augmented pulmonary inflammation
and lymph node lymphocyte numbers through 4 weeks. By 8
weeks, pulmonary inflammation had begun to wane with the
additional challenges, although the numbers of lymphocytes in
the draining lymph nodes remained elevated (Fig. 2B). Thus,
repeated exposure promoted sustained expansion of the drain-
ing lymph nodes, while the pulmonary inflammatory response
peaked and waned.
We next used flow cytometry to identify specific myeloid cell
populations in the lungs and to further delineate the dynamics
of the inflammatory response through eight weekly challenges
with A. fumigatus conidia. Consistent with our histological
analysis, we observed a significant difference in the number of
granulocytes between untreated mice and those challenged
twice (Fig. 3). However, mice challenged four times with
conidia had 6-fold more eosinophils in the lungs than mice
challenged twice (Fig. 3). By eight challenges, there were sig-
nificantly fewer neutrophils and a trend toward fewer eosino-
phils in the lungs. The numbers of basophils in the lungs
increased significantly between two and four challenges and
then decreased slightly by eight challenges (Fig. 4). The mono-
cyte/macrophage/DC population was numerically the largest
cell population in the lungs. This heterogeneous population
followed kinetics similar to those of the other myeloid cells,
with a significant peak at four challenges and a significant
decline by eight challenges. These data provide quantitative
analyses that are consistent with the histological observations
described above and confirm that, after peaking at four chal-
lenges, the influx of eosinophils and other myeloid cells did not
continue to grow despite continued A. fumigatus challenges.
Activation of CD4 T cells in the lungs and lymph node in
response to repeated pulmonary challenges with conidia. We
FIG. 2. Fungal clearance and pulmonary inflammation following
intranasal challenges. (A) Twenty-four hours after the final challenge,
lungs were digested; an aliquot of the digest was serially diluted and
plated onto SDA medium; and mycelial colonies were counted. Bars
show the average numbers of viable conidia per lung detected 24 h
after no challenge or two, four, or eight challenges. (B) Leukocyte
influx into the lungs during the inflammatory response and expansion
of lymphocytes in the mediastinal (draining) lymph node following
repeated exposure to A. fumigatus conidia. Data are means standard
errors of the means; numbers of animals and replicates are provided in
Materials and Methods. *, P 	 0.05 for comparison to no exposure; ‡,
P 	 0.05 for comparison to the previous “challenge” time point.
FIG. 3. Neutrophil and eosinophil influx into the lungs during the
inflammatory response. Data are means  standard errors of the
means; numbers of animals and replicates are provided in Materials
and Methods. *, P 	 0.05 for comparison to no exposure; ‡, P 	 0.05
for comparison to the previous “challenge” time point.
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next examined the dynamics of the CD4 T cell response to
repeated challenges with A. fumigatus conidia. First, we quan-
tified CD4, CD8, and B lymphocyte levels in the lungs by flow
cytometry as described in Materials and Methods. The number
of CD4 T cells did not increase significantly following two
challenges, but four challenges induced a 5-fold increase in the
total number of CD4 T cells in the lungs, which remained
elevated through eight challenges (Fig. 5). There was a similar
influx of B cells into the lungs; however, CD8 T cell numbers
remained relatively low throughout. In the draining lymph
nodes, the CD4 T and B cell populations expanded as early as
two challenges and continued to expand through four chal-
lenges but then leveled off and remained elevated through
eight challenges (Fig. 5), concurrently with the increase in
serum IgE levels at four and eight challenges over those for
unchallenged controls (see Fig. 9A).
We hypothesized that differences in CD4 T cell activation
might account for the development and waning of the pulmo-
nary inflammatory response. Just two exposures to conidia
resulted in an increase in the percentage of pulmonary CD4 T
cells that were activated (CD44high CD69), even though the
number of CD4 T cells in the lungs did not increase signifi-
cantly (Fig. 6). The proportion of activated CD4 T cells did not
change significantly between two, four, and eight challenges
(remaining high, approximately 70%). In the lymph node, the
fraction of activated CD4 T cells was lower than that in the
lungs and remained constant throughout the course of expo-
sure, although the number of activated CD4 T cells increased
coincidently with the increase in the total number of CD4 T
cells in the lymph nodes (Fig. 6). The activation marker anal-
ysis supports the concept that an adaptive immune response
begins to develop between two to four challenges and is sus-
tained, despite the presence of less pulmonary inflammation,
through eight exposures.
Polarization of the CD4 T cell response during repeated
challenges with conidia. We next investigated whether changes
in the polarization of the CD4 TH cell response accounted for
the development of the pulmonary inflammatory response by
four challenges and its subsequent waning by eight challenges.
Using intracellular flow cytometry, we observed that after two
challenges, the only notable change was an increase in the
number of IL-10 CD4 T cells (Fig. 7A). By four challenges,
there were marked increases in the numbers of IL-4, IL-17,
and IFN- CD4 T cells. After eight challenges, the numbers
of IL-4, IL-17, IFN-, and IL-10 T cells all remained
elevated in the lungs. Repeated A. fumigatus exposure also
resulted in the recruitment of IFN- IL-17 CD4 T cells,
although this was a minor population (Fig. 7B). These data
demonstrate that repeated exposure to A. fumigatus conidia
induces the codevelopment of TH1, TH2, and TH17 responses
in the lungs by four exposures, that these responses are main-
tained through eight exposures, and that changes in CD4 T cell
polarization do not account for the reduction in myeloid cell
numbers later in the response.
We next investigated whether an increase in the ratio of
regulatory to effector CD4 T cells could account for the waning
FIG. 4. Basophil and monocyte/macrophage/DC influx into the
lungs during the inflammatory response. M
, macrophages. Data are
means  standard errors of the means; numbers of animals and rep-
licates are provided in Materials and Methods. *, P 	 0.05 for com-
parison to no exposure; ‡, P 	 0.05 for comparison to the previous
“challenge” time point.
FIG. 5. Expansion of the lymphocyte populations in both the lung
and the mediastinal lymph node. Data are means  standard errors of
the means; numbers of animals and replicates are provided in Mate-
rials and Methods. *, P 	 0.05 for comparison to no exposure; ‡, P 	
0.05 for comparison to the previous “challenge” time point.
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of the inflammatory response. In the draining lymph nodes, the
percentage of regulatory T (Treg) cells within the pool of CD4
T cells was constant over the course of exposure to A. fumiga-
tus conidia. In the lungs, the percentage of Treg (CD25

Foxp3) cells increased nearly 50% after two exposures, con-
sistent with the observed increase in the number of IL-10
CD4 T cells, suggesting a higher regulatory/nonregulatory ratio
early in the response (Fig. 8). As the number of challenges
increased, the total number of Treg cells also increased. How-
ever, the relative proportion of Treg cells dropped (i.e., an
increase in the non-Treg/Treg cell ratio) concurrently with the
development of the inflammatory response. Despite the pres-
ence of less inflammation, the ratio of non-Treg cells to Treg
cells remained high at eight challenges, ruling out an expansion
of the Treg population as a major factor in modulating the
inflammatory response.
Immune recall response to repeated pulmonary Aspergillus
challenges. In our final set of studies, we addressed whether
the inflammatory response would progress or resolve after four
challenges if there were no additional conidial challenges.
Since the numbers of inflammatory cells in the bronchoalveo-
lar lavage fluid were determined in these studies, they also
provided quantitative data to address whether inflammation
was similar in the airway and parenchymal pulmonary com-
partments. Both mice challenged four times and mice chal-
lenged eight times had significant leukocytic infiltrates in the
airways (Fig. 9B). However, the infiltrate in the mice chal-
lenged four times was dominated by eosinophils, while that in
the mice challenged eight times was dominated by macro-
phages (Fig. 9C). These results are similar to those seen for the
whole-lung digests except that the diminished eosinophilia was
more pronounced in the airways. If the mice were challenged
four times and then left to rest for 4 weeks, the inflammatory
response resolved to near baseline, except for the number of
lymphocytes, which remained slightly elevated. We also elic-
ited a recall response during the resolution phase by challeng-
ing a group of mice previously exposed four times after 2 weeks
of resolution (Fig. 9B and C). The recall response was similar
to the peak allergic response noted after 4 weeks in terms of
FIG. 6. CD4 T cell activation in response to A. fumigatus conidia in
the lung and lymph nodes. Lung and lymph node CD4 T cells were
isolated via gating, and those that were CD44high CD69 were counted
as activated. Both the percentage and the total number of activated
CD4 T cells in the lung and lymph nodes were calculated for each
mouse and averaged for each time point. Data are means  standard
errors of the means; numbers of animals and replicates are provided in
Materials and Methods. *, P 	 0.05 for comparison to no exposure; ‡,
P 	 0.05 for comparison to the previous “challenge” time point.
FIG. 7. Distinct CD4 cytokine profiles in the lung following each stage of the immune response to A. fumigatus. (A) Cells taken from the lung
were stimulated for 6 h with PMA and ionomycin and were then stained with fluorescently labeled antibodies specific for CD45 and CD4. Following
permeabilization, cells were stained for intracellular IFN-, IL-4, IL-10, and IL-17 expression. The mean total number of CD4 T cells expressing
each cytokine is shown. (B) The mean number of CD4 T cells expressing multiple cytokines is shown. Data are means  standard errors of the
means; numbers of animals and replicates are provided in Materials and Methods. *, P 	 0.05 for comparison to no exposure; ‡, P 	 0.05 for
comparison to the previous “challenge” time point.
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airway eosinophilia (Fig. 9C), suggesting that continued expo-
sure throughout 8 weeks, in contrast to intermittent exposure,
resulted in the attenuation of the allergic response in spite of
the presence of primed cells capable of promoting a vigorous
hypersensitivity response.
DISCUSSION
We have demonstrated that repeated exposure of an immu-
nocompetent host to A. fumigatus conidia does not result in
invasive aspergillosis or fatal disease but does result in the
development of chronic pulmonary inflammation. Repeated
exposure to A. fumigatus conidia induces the coevolution of
TH1, TH2, and TH17 responses in the lungs by four exposures,
and these responses are maintained through eight exposures.
We observed striking increases in the numbers of IFN-- and
IL-17-producing CD4 T cells between two and four challenges.
IFN- IL-17 double-positive T cells are associated with inflam-
mation in several models of autoimmunity and graft rejection
(11, 15, 45, 48), and their presence suggests a role for IL-17 in
maintaining the inflammatory response to Aspergillus. How-
ever, by eight exposures, myeloid cell recruitment is dimin-
ished, including that of airway eosinophils, and changes in CD4
T cell polarization or Treg numbers do not account for the
waning inflammatory response with continued exposure. The to-
tal time of exposure is not a factor, because if, during the same
8-week period, exposures are stopped for 2 weeks, then inflam-
mation resolves and a robust recall response occurs.
Repeated exposure to viable A. fumigatus conidia induced
both CD4 TH2 and TH1 cells. Several previous reports have
demonstrated that a single exposure to A. fumigatus conidia
leads primarily to the priming of CD4 TH1 cells (9, 31) and
that exposure to A. fumigatus hyphae or antigen extracts leads
primarily to the priming of CD4 TH2 cells (9, 36). Systemic
priming and airway exposure to A. fumigatus antigens establish
a TH2-mediated allergic airway disease (AAD) that can sub-
FIG. 8. Regulatory CD4 T cells in the lung and lymph node during repeated A. fumigatus exposure. Cells taken from both the lung and the
mesenchymal lymph node were stained for CD45, CD4, and CD25. Then, following permeabilization, cells were stained for intracellular Foxp3
expression. The non-Treg/Treg ratio was determined by comparing the percentage of CD4 T cells that were double positive for CD25 and Foxp3
to the percentage of those that were double negative. Each bar represents the mean for mice at a single time point, and error bars represent
standard errors of the means. Numbers of animals and replicates are provided in Materials and Methods. *, P 	 0.05 for comparison to no
exposure; ‡, P 	 0.05 for comparison to the previous “challenge” time point.
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sequently be augmented by exposure to conidia, indicating that
previously expanded CD4 TH2 cells will respond to conidia
(6). Differences in the CD4 T cell response to conidia may
depend on the dosing and frequency used in the various stud-
ies. In the studies mentioned above that resulted primarily in
CD4 TH1 priming, 5 to 100 times the number of conidia used
in our study were administered (9, 31). The differential effect
of dose and frequency of exposure to A. fumigatus conidia has
clinical relevance, because TH1-associated hypersensitivity
pneumonitis results from very high dose exposure, generally in
an occupational setting (1, 20, 57, 65).
It is interesting that in spite of the presence of TH2 and TH1
cells, the CD4 T cell-dependent hypersensitivity disease that
developed after repeated exposure to conidia had many fea-
tures of AAD, a TH2 disease. TH1 cells can abrogate TH2
cell-mediated AAD (35); however, TH1 responses to viral in-
fections are known to exacerbate asthma symptoms (4, 42).
Furthermore, it has been demonstrated in mice that a TH1-
promoting rhinovirus infection can augment the TH2 response
in AAD and that a preexisting TH2 response augmented the
TH1 response to rhinovirus infection (3). The data generated
in the present study support the emerging understanding that
allergic diseases are not simply the result of an imbalance in
counterregulatory TH1 and TH2 responses (73). Rather, cur-
rent evidence suggests that both TH2 and TH1 responses are
inflammatory and that both are subject to control by myriad
regulatory mechanisms, such as those mediated by dedicated
regulatory T cells.
Viable conidia could be detected in lung homogenates 24 h
after each challenge, providing a sustained source of antigen or
inflammatory stimuli during the evolving CD4 T cell response
despite a lack of hyphal formation. Neutrophils, a major cell
type during the early phases of the response, are well known to
play a central role in the host defense against Aspergillus (5, 29,
43, 44, 64) and were seen at all stages of the response, partic-
ularly at early stages prior to the engagement of the adaptive
response. Levels of lung eosinophils, serum IgE, and IL-4
CD4 T cells, all hallmarks of a TH2 response, were elevated at
four and eight exposures. The chronic inflammatory response
included the recruitment of antigen-presenting cells, such as
basophils, dendritic cells, macrophages, CD4 T cells, and B
cells, all of which are capable of driving TH2, TH1, TH17, or
Treg responses.
Expansion of the regulatory T cell population is important
for limiting disease, because Treg cells ultimately aid in the
clearance of fungi by limiting TH1 inflammation (17) or damp-
ening TH2 hypersensitivity reactions (8, 16). Exposure to A.
fumigatus conidia or fungal glucan has been reported to induce
regulatory responses via Toll-like receptor 2 (TLR2) and dec-
tin-1 (19, 46). However, in aspergillosis studies using high
doses of conidia (108 spores per mouse), a strong TH1 response
occurs 1 week after the initial exposure (32), rather than the
Treg response that we have reported here during repeated
exposure to A. fumigatus conidia, and there is no subsequent
TH2 reaction.
There are several possible explanations, then, for the tran-
sition from tolerance to inflammation that we observed during
repeated exposure to A. fumigatus conidia. One possibility is
that the accumulation of innate cells eventually overwhelms
the regulatory response. Chitin—which is generated following
conidial germination—can drive an accumulation of innate
cells, stimulating inflammation that ultimately leads to an al-
lergic response (61). We describe here that viable conidia are
still present 24 h after challenge and that germinating fungi can
be detected in the lungs even when low concentrations of
conidia are used. Thus, it is possible that chitin production
FIG. 9. Characterization of the inflammatory response to pro-
longed continuous or intermittent A. fumigatus inhalational exposure.
(A) Serum IgE was measured for each mouse in two independent
experiments. Bars represent mean relative serum IgE levels in mice
challenged four and eight times. *, P 	 0.05 versus no challenge.
(B) After mice were treated with variable numbers of weekly exposures
to A. fumigatus (for which the PBS vehicle was sometimes substituted),
airway leukocytes were recovered by BAL and were counted under a
light microscope. The numbers of exposures to the PBS vehicle are
given in parentheses, and the order of the numbers indicates the
sequence of the exposures [e.g., “4 (2) 2” indicates 4 weekly A. fumiga-
tus exposures followed by 2 weekly PBS exposures, which, in turn, were
followed by 2 weekly A. fumigatus exposures]. Each bar represents the
mean of data compiled from two independent experiments, except for
“0” and “4 (4),” for each of which data were from one experiment (4
mice per group per experiment). (C) After mice were treated with
variable numbers of weekly exposures to A. fumigatus (for which con-
trol exposures to PBS vehicle were sometimes substituted), flow cyto-
metric leukocyte differential analyses were performed on BAL fluid
cells. Data are means  standard errors of the means; numbers of
animals and replicates are provided in Materials and Methods. *, P 	
0.05 for comparison to no exposure.
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results in an innate response that outpaces the tolerance re-
sponse and eventually results in the engagement of TH2 adap-
tive immunity. Another possibility is that suppression of the
TH1 response by Treg cells facilitates the development of the
TH2 response. The TH1 response can be responsible for tissue
damage (69), so it is possible that the immune system dampens
the TH1 response to a dose of conidia that can easily be cleared
by the innate immune system. Such TH1 control could, in turn,
allow the expansion of a TH2 response, since TH1 and TH2
responses are often reciprocally regulated. The latter hypoth-
esis is supported by our studies demonstrating increased num-
bers of IL-17-producing CD4 T cells during the response, be-
cause the TH17 response can be negatively regulated by IFN-
(21).
Like the development of the TH2 response, the TH17 adap-
tive immune response during repeated exposure to A. fumiga-
tus conidia may result from a combination of factors. The
initial TH17 adaptive immune response may be triggered sim-
ply by the presence of conidia: like regulatory T cells, TH17
cells are promoted by fungal cell wall components via interac-
tion with dectin-1 (23, 71). In addition, Treg cells can facilitate
the differentiation of TH17 cells (37, 74), and regulatory T cells
themselves can be converted to TH17 cells (59), a process that
is facilitated by DC (55). Thus, the initial TH17 response seen
following two challenges may be driven by the conversion of
regulatory T cells to TH17 cells. This process would be aided by
the dampened TH1 response, since the development of TH17
cells is inhibited by TH1 and TH2 cytokines. On the other hand,
CD4 T cells already committed to the TH17 lineage are resis-
tant to TH1- or TH2-mediated suppression (26), which could
explain why we observed that IL-17-producing CD4 T cells
continue to expand even during the TH2-driven inflammatory
response that follows four challenges. The TH17 T cells in our
study are also likely playing an active role in shaping the re-
action to conidia, since TH17 regulates TH1 differentiation (49,
75) and dampens the production of indoleamine-2,3-dioxyge-
nase (IDO). While IDO can inhibit TH1 activity, it also sup-
presses the cytotoxic potential of neutrophils. This would be
consistent with the persistent number of viable conidia seen in
the lungs even after eight challenges, because TH17-induced
IDO reduction and subsequent neutrophil inhibition have
been shown to inhibit fungal clearance (17).
We observed that TH17 cell levels increased during repeated
exposures to A. fumigatus conidia, while TH2 cell levels re-
mained steady or decreased. Previous studies have indicated
that TH2 airway inflammation is enhanced by TH17 cells (72).
However, in the context of repeated A. fumigatus exposures, it
may be that the TH17 response, rather than suppressing the
TH2 response, becomes the dominant adaptive response
through attrition. Repeated exposure to an antigen leads to
restimulation-induced death of CD4 T cells, but it has been
reported in autoimmune disease models that TH17 cells are
resistant to this form of apoptosis (30). To our knowledge,
there have been no reports demonstrating that the TH17 re-
sponse directly regulates TH2 responses, so the presence of
TH17 cells does not explain the dampening of the inflamma-
tory response between four and eight challenges. However,
multiple reports have shown that IL-17 both exacerbates and
attenuates inflammatory TH2 responses and that the function
of IL-17 is timing dependent (28, 68).
Thus, the emergent TH17 response may arise as an imperfect
immune compromise when an individual is dealing with re-
peated exposure to low levels of conidia. The TH17 response
hinders TH1-mediated clearance of fungi and can promote
severe neutrophil-mediated tissue inflammatory pathology as-
sociated with infection (17), but on its own the TH17 response
has antifungal properties (22, 25, 38, 39). A persistent TH1
response would result in damage to the tissue of the lung, but
its suppression facilitates an emergent TH2 response that does
little to aid in the clearance of nonhyphal A. fumigatus. There-
fore, it is likely that repeated pulmonary exposure to A. fu-
migatus conidia eventually leads to immune homeostasis and
the induction of non-T cell regulatory pathways that result in
the least possible tissue damage while still controlling conidial
germination (12, 13).
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